APA (7th ed.) Citation

Yao, Y., Zhou, J., Song, J., & Chen, C. (2025). Ruxolitinib enhances gastric cancer to chemotherapy by suppressing JAK/STAT3 and inducing mitochondrial dysfunction and oxidative stress. Immunopharmacology & Immunotoxicology, 47(2), 263. https://doi.org/10.1080/08923973.2025.2470344

Chicago Style (17th ed.) Citation

Yao, Yang, Jun Zhou, Jing Song, and Cheng Chen. "Ruxolitinib Enhances Gastric Cancer to Chemotherapy by Suppressing JAK/STAT3 and Inducing Mitochondrial Dysfunction and Oxidative Stress." Immunopharmacology & Immunotoxicology 47, no. 2 (2025): 263. https://doi.org/10.1080/08923973.2025.2470344.

MLA (9th ed.) Citation

Yao, Yang, et al. "Ruxolitinib Enhances Gastric Cancer to Chemotherapy by Suppressing JAK/STAT3 and Inducing Mitochondrial Dysfunction and Oxidative Stress." Immunopharmacology & Immunotoxicology, vol. 47, no. 2, 2025, p. 263, https://doi.org/10.1080/08923973.2025.2470344.